Zobrazeno 1 - 10
of 12 783
pro vyhledávání: '"rsv"'
Autor:
Daisuke Kurai, Akiko Mizukami, Victor Preckler, Frederik Verelst, Daniel Molnar, Taizo Matsuki, Yufan Ho, Ataru Igarashi
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 303-311 (2024)
ABSTRACTBackground Respiratory syncytial virus (RSV), a common respiratory pathogen, can lead to severe symptoms, especially in older adults (OA). A recently developed RSV prefusion F protein (RSVPreF3 OA) vaccine confers high protection against RSV
Externí odkaz:
https://doaj.org/article/5257110ff0d74e0b89f9b9977b98216e
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 3, Pp 255-269 (2024)
INTRODUCTION. Respiratory syncytial virus (RSV) is one of the most widespread pathogens that typically cause acute upper and lower respiratory tract infections in children and adults. Monoclonal antibody products have long been used for passive immun
Externí odkaz:
https://doaj.org/article/3ac3c8b3f3eb41a5ab57ec08849fc963
Autor:
Dhayhi NS, Aqeel A, Ghazwani S, Gosadi IM, AlQassimi HM, Thubab A, Sairam IA, Hakami MA, Sawan FA, Asiry SM, Khalifa M, Daghreeri H, Badawy A, Ghawi AA, Arishi H, Almudeer A, Shrwani KJ, Alhazmi AH
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 5179-5187 (2024)
Nabil S Dhayhi,1,* Ali Aqeel,2,* Salman Ghazwani,3 Ibrahim M Gosadi,4 Haleemah Mohammed AlQassimi,5 Abdullah Thubab,6 Ibrahim Abdullah Sairam,6 Majed Ahmed Hakami,6 Fahd Ahmed Sawan,6 Sabreen Mohammed Asiry,7 Mawahib Khalifa,7 Hadi Daghreeri,
Externí odkaz:
https://doaj.org/article/85b990e49be54838b94337777057fe46
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Severe acute respiratory infection (SARI) is a major cause for hospital admission and associated with high mortality among children worldwide. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza viruses and res
Externí odkaz:
https://doaj.org/article/4072f3cfc0804fe99f57612ccc6ccd6c
Autor:
Fabienne Krauer, Felix Guenther, Marina Treskova-Schwarzbach, Viktoria Schoenfeld, Mihaly Koltai, Mark Jit, David Hodgson, Udo Schneider, Ole Wichmann, Thomas Harder, Frank G. Sandmann, Stefan Flasche
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Recently, several novel RSV immunisation products that protect infants and older adults against RSV disease have been licensed in Europe. We estimated the effectiveness and efficiency of introducing these RSV immunisation strategi
Externí odkaz:
https://doaj.org/article/ca62e9e98ff34d25ab8f541c091ac643
Autor:
Claudia Vanetti, Irma Saulle, Valentina Artusa, Claudia Moscheni, Gioia Cappelletti, Silvia Zecchini, Sergio Strizzi, Micaela Garziano, Claudio Fenizia, Antonella Tosoni, Martina Broggiato, Pasquale Ogno, Manuela Nebuloni, Mario Clerici, Daria Trabattoni, Fiona Limanaqi, Mara Biasin
Publikováno v:
Microbial Cell, Vol 11, Pp 353-367 (2024)
Concurrent infections with two or more pathogens with analogous tropism, such as RSV and SARS-CoV-2, may antagonize or facilitate each other, modulating disease outcome. Clinically, discrepancies in the severity of symptoms have been reported in chil
Externí odkaz:
https://doaj.org/article/2f59277dee1040b7adfa830988e3b6fd
Autor:
Jocelyn Moyes, Stefano Tempia, Sibongile Walaza, Adam L. Cohen, Florette Treurnicht, Orienka Hellferscee, Nicole Wolter, Anne von Gottberg, Halima Dawood, Ebrahim Variava, Kathleen Kahn, Shabir A. Madhi, Cheryl Cohen
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Identifying risk factors for respiratory syncytial virus (RSV)–associated severe acute respiratory illness (SARI) will assist with targeting vaccine interventions. Methods Using surveillance data from South Africa (2012–2018),
Externí odkaz:
https://doaj.org/article/f53b61d300d645698e38030a2748a7fe
Autor:
Ferdinand Cacho, Tebeb Gebretsadik, Larry J. Anderson, James D. Chappell, Christian Rosas-Salazar, Justin R. Ortiz, Tina Hartert
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 10, Pp 2199-2202 (2024)
In a population-based birth cohort study of respiratory syncytial virus surveillance in the United States, 897/1,680 (53.4%) children were infected during infancy; 25 (2.8%) of those were hospitalized. Among symptomatic infants, 143/324 (44.1%) had l
Externí odkaz:
https://doaj.org/article/770be20b1f5b4ddf9a64287027292fd2
Publikováno v:
Journal of Intensive Medicine, Vol 4, Iss 4, Pp 405-416 (2024)
The burden of respiratory syncytial virus (RSV) disease is widely recognized. Main risk factors for severe disease, such as extreme ages, chronic cardiopulmonary conditions, and immunosuppression, typically coincide with poorer outcomes. While the ma
Externí odkaz:
https://doaj.org/article/c947b55558154753b8a0657468a6a09e
Autor:
Bochun Cao, Menglu Li, Xiaoping Li, Xianyan Ji, Lin Wan, Yingying Jiang, Lu Zhou, Fang Gong, Xiangjie Chen
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-18 (2024)
Abstract Background Respiratory syncytial virus (RSV) is a prominent etiological agent of lower respiratory tract infections in children, responsible for approximately 80% of cases of pediatric bronchiolitis and 50% of cases of infant pneumonia. Desp
Externí odkaz:
https://doaj.org/article/35a98ea193c64d30959563f74eac7370